Comprehensive Psychiatry
Volume 48, Issue 6 , Pages 516-521, November 2007

Eating disorders and illness burden in patients with bipolar spectrum disorders

Portions of this article were presented at the 2007 International Conference on Eating Disorders, Baltimore, MD, May 2-5, and the Seventh International Conference on Bipolar Disorder, Pittsburgh, PA, June 7-9, 2007.

Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA

published online 20 August 2007.

Abstract 

Objectives

The objectives of the study were to evaluate the clinical significance of lifetime eating disorder comorbidity in a well-defined sample of patients with bipolar spectrum disorders and to describe cognitive correlates of disordered eating in this group.

Method

Twenty-six bipolar patients with a lifetime history of a Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)–defined eating disorder (n = 17) or a clinically significant subthreshold eating disorder (n = 9) (ED group) were compared with 46 bipolar patients with no history of an eating disorder (no-ED group) on demographic and clinical characteristics at study presentation, history of bipolar illness, and other psychiatric comorbidity. Measures included the Structured Clinical Interview for the DSM-IV Axis I Disorders, the Clinical Global Impression–Severity Scale–Bipolar Version (CGI-S-BP), and the Eating Disorder Examination. Height and weight were recorded to calculate body mass index.

Results

Patients in the ED group were heavier and were rated as more symptomatic on the CGI-S-BP than were patients in the no-ED group. The ED group also had a higher number of lifetime depressive episodes and greater psychiatric comorbidity, excluding eating and mood disorders. Finally, after controlling for body mass index and CGI-S-BP rating, patients in the ED group had significantly higher Eating Disorder Examination Restraint, Eating Concern, Shape Concern, Weight Concern, and Global scores than did patients in the no-ED group.

Conclusions

These findings highlight the need for a renewed emphasis on the evaluation and management of weight and eating in the mood disorders. In particular, this research suggests that eating disorder comorbidity may be a marker for increased symptom load and illness burden in bipolar disorder.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr Marcus has served as a consultant to GlaxoSmithKline and Sanofi Aventis. Dr Fagiolini is on the advisory board for Pfizer Inc and Bristol-Meyers Squibb and is in the speaker bureau of Bristol-Meyers Squibb, Eli Lilly Italy, Pfizer Inc, and Shire.

PII: S0010-440X(07)00076-4

doi:10.1016/j.comppsych.2007.05.012

Comprehensive Psychiatry
Volume 48, Issue 6 , Pages 516-521, November 2007